|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.985 USD | -1.83% |
|
-8.81% | +75.50% |
| 07-14 | Cumberland Pharmaceuticals Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
| 07-13 | Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 | CI |
| Market Cap | 107M 93.76M 87.1M 80.11M 150M 10.32B 153M 1.04B 406M 5.04B 400M 392M 17.47B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 105M 92.65M 86.07M 79.16M 148M 10.2B 151M 1.03B 401M 4.98B 395M 387M 17.26B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.09% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -1.83% | ||
| 1 week | -8.81% | ||
| Current month | +7.79% | ||
| 1 month | +19.81% | ||
| 3 months | +79.10% | ||
| 6 months | +77.74% | ||
| Current year | +75.50% |
| 1 week | 5.75 |  | 8.06 |
| 1 month | 5.75 | | 8.09 |
| Current year | 2.69 | | 8.09 |
| 1 year | 1.85 | | 8.09 |
| 3 years | 1.04 | | 8.09 |
| 5 years | 1.04 | | 8.09 |
| 10 years | 0 | | 8.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
| Director/Board Member | 74 | 10/09/2010 | |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 A | Free | Compliance Officer | 2,500 | 0.0167% | ||
| 3/18/26 A | Free | Chief Financial Officer | 3,000 | 0.0201% | ||
| 3/18/26 A | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.83% | -8.81% | +96.21% | +362.58% | 107M | |
| +1.97% | +1.43% | +48.44% | +158.18% | 1,037B | |
| +1.42% | +3.72% | +53.32% | +51.55% | 615B | |
| +1.43% | +0.99% | +34.83% | +79.44% | 448B | |
| +5.14% | +5.84% | +37.54% | +27.28% | 326B | |
| +1.85% | +4.64% | +38.53% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | -0.02% | +20.14% | +57.80% | 198B | |
| +0.40% | -3.99% | +15.23% | +68.50% | 162B | |
| Average | +1.21% | +0.13% | +34.24% | +82.08% | 355.75B | |
| Weighted average by Cap. | +1.59% | +1.47% | +36.34% | +75.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.3M 30.94M 28.46M 53.37M 3.67B 54.32M 370M 144M 1.79B 142M 139M 6.21B | 44.52M 39.16M 36.38M 33.46M 62.74M 4.31B 63.87M 435M 170M 2.1B 167M 164M 7.3B |
| Net income | -6.48M -5.7M -5.29M -4.87M -9.13M -628M -9.3M -63.31M -24.69M -306M -24.33M -23.8M -1.06B | -2.84M -2.49M -2.32M -2.13M -4M -275M -4.07M -27.71M -10.81M -134M -10.65M -10.42M -465M |
| Net Debt | 2.61M 2.29M 2.13M 1.96M 3.68M 253M 3.74M 25.48M 9.94M 123M 9.79M 9.58M 427M | -1.26M -1.11M -1.03M -950K -1.78M -122M -1.81M -12.35M -4.82M -59.72M -4.75M -4.64M -207M |
Employees
93
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | $6.985 | -1.83% | 418,776 |
| 22/07/26 | $7.115 | -9.36% | 147,811 |
| 21/07/26 | $7.850 | +7.53% | 137,146 |
| 20/07/26 | $7.300 | +6.73% | 119,792 |
| 17/07/26 | $6.840 | -10.70% | 239,781 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
